Evotec SE (EVO) Cash & Equivalents (2009 - 2026)

Evotec SE (EVO) has 10 years of Cash & Equivalents data on file, last reported at $454146.3 in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 51.29% year-over-year to $454146.3; the trailing twelve-month figure through Mar 2026 stood at $454146.3 (up 51.29% YoY), and the FY2025 full-year result was $487.17, down 100.0% from the prior year.
• Cash & Equivalents climbed to $454146.3 in Q1 2026, from $487.17 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $465.3 billion in Q1 2024 to a low of $487.17 in Q4 2025.
• A 5-year average of $55.4 billion and a median of $741290.6 in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents tumbled 100.0% in 2025 and surged 51.29% in 2026, its largest moves.
• Tracing EVO's Cash & Equivalents over 5 years: stood at $423.6 million in 2022, then gained by 29.78% to $549.7 million in 2023, then tumbled by 40.44% to $327.4 million in 2024, then plunged by 100.0% to $487.17 in 2025, then soared by 93120.93% to $454146.3 in 2026.
• Business Quant data shows EVO's Cash & Equivalents at $454146.3 in Q1 2026, $487.17 in Q4 2025, and $203460.0 in Q3 2025.